Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Mefenamic acid
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mefenamic acid 500mg tablets
1001010N0AAADAD
|
Mefenamic acid | Mefenamic acid | Musculoskeletal and Joint Diseases | 48,303 |
|
Mefenamic acid 250mg capsules
1001010N0AAAAAA
|
Mefenamic acid | Mefenamic acid | Musculoskeletal and Joint Diseases | 20,549 |
|
Mefenamic acid 250mg tablets
1001010N0AAAJAJ
|
Mefenamic acid | Mefenamic acid | Musculoskeletal and Joint Diseases | 3,914 |
|
Ponstan 250mg capsules
1001010N0BBAAAA
|
Ponstan | Mefenamic acid | Musculoskeletal and Joint Diseases | 661 |
|
Ponstan Forte 500mg tablets
1001010N0BBABAD
|
Ponstan | Mefenamic acid | Musculoskeletal and Joint Diseases | 488 |
|
Mefenamic acid 50mg/5ml oral suspension
1001010N0AAABAB
|
Mefenamic acid | Mefenamic acid | Musculoskeletal and Joint Diseases | 95 |
|
Dysman 250 capsules
1001010N0BDACAA
|
Dysman | Mefenamic acid | Musculoskeletal and Joint Diseases | No data available |
|
Dysman 500 tablets
1001010N0BDADAD
|
Dysman | Mefenamic acid | Musculoskeletal and Joint Diseases | No data available |
|
Mefenamic acid 250mg/5ml oral suspension
1001010N0AAAGAG
|
Mefenamic acid | Mefenamic acid | Musculoskeletal and Joint Diseases | No data available |
|
Mefenamic acid 500mg/5ml oral suspension
1001010N0AAAHAH
|
Mefenamic acid | Mefenamic acid | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.